Works matching IS 14642662 AND DT 2014 AND VI 15 AND IP 6

Results: 10

Community HIV-1 drug resistance is associated with transmitted drug resistance.

Published in:

HIV Medicine, 2014, v. 15, n. 6, p. 339, doi. 10.1111/hiv.12122

By:

Tilghman, MW;
Pérez‐Santiago, J;
Osorio, G;
Little, SJ;
Richman, DD;
Mathews, WC;
Haubrich, RH;
Smith, DM

Publication type:

Article

Linkage to care following community-based mobile HIV testing compared with clinic-based testing in Umlazi Township, Durban, South Africa.

Published in:

HIV Medicine, 2014, v. 15, n. 6, p. 367, doi. 10.1111/hiv.12115

By:

Bassett, IV;
Regan, S;
Luthuli, P;
Mbonambi, H;
Bearnot, B;
Pendleton, A;
Robine, M;
Mukuvisi, D;
Thulare, H;
Walensky, RP;
Freedberg, KA;
Losina, E;
Mhlongo, B

Publication type:

Article

Repeat antenatal HIV testing in the third trimester: a study of feasibility and maternal uptake rates.

Published in:

HIV Medicine, 2014, v. 15, n. 6, p. 362, doi. 10.1111/hiv.12110

By:

Williams, B;
Costello, M;
McHugh, E;
Le Prevost, M;
Phil‐Ebosie, A;
Tilsed, C;
McSorley, J;
Murphy, S;
Brook, G;
Williams, A

Publication type:

Article

Response to letter 'Poor citation, coding and reporting: a review of adherence-enhancing interventions for highly active antiretroviral therapy creates an inaccurate picture of the state of the field'.

Published in:

HIV Medicine, 2014, v. 15, n. 6, p. 383, doi. 10.1111/hiv.12138

By:

Mathes, T;
Pieper, D;
Antoine, S‐L;
Eikermann, M

Publication type:

Article

Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir.

Published in:

HIV Medicine, 2014, v. 15, n. 6, p. 330, doi. 10.1111/hiv.12121

By:

Martinez, E;
Gonzalez‐Cordon, A;
Ferrer, E;
Domingo, P;
Negredo, E;
Gutierrez, F;
Portilla, J;
Curran, A;
Podzamczer, D;
Murillas, J;
Bernardino, JI;
Santos, I;
Carton, JA;
Peraire, J;
Pich, J;
Perez, I;
Gatell, JM

Publication type:

Article

Prevalence of and risk factors for pulmonary abnormalities in HIV-infected patients treated with antiretroviral therapy.

Published in:

HIV Medicine, 2014, v. 15, n. 6, p. 321, doi. 10.1111/hiv.12117

By:

Sampériz, G;
Guerrero, D;
López, M;
Valera, JL;
Iglesias, A;
Ríos, Á;
Campins, A;
Sala, E;
Murillas, J;
Togores, B;
Palmer, J;
Rodriguez, M;
Soriano, JB;
Sauleda, J;
Riera, M;
Agusti, A

Publication type:

Article

Poor citation, coding and reporting: a review of adherence-enhancing interventions for highly active antiretroviral therapy creates an inaccurate picture of the state of the field.

Published in:

HIV Medicine, 2014, v. 15, n. 6, p. 381, doi. 10.1111/hiv.12139

By:

Bruin, M;
Simoni, J;
Amico, KR;
Parsons, JT;
Fisher, J;
Safren, SA

Publication type:

Article

Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks.

Published in:

HIV Medicine, 2014, v. 15, n. 6, p. 373, doi. 10.1111/hiv.12123

By:

Bloch, M;
Tong, WWY;
Hoy, J;
Baker, D;
Lee, FJ;
Richardson, R;
Carr, A

Publication type:

Article

Multiple hepatitis C virus ( HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28 B genotype on spontaneous clearance.

Published in:

HIV Medicine, 2014, v. 15, n. 6, p. 355, doi. 10.1111/hiv.12127

By:

Ingiliz, P;
Krznaric, I;
Stellbrink, H‐J;
Knecht, G;
Lutz, T;
Noah, C;
Stocker, H;
Obermeier, M;
Dupke, S;
Boesecke, C;
Rockstroh, JK;
Baumgarten, A;
Hoffmann, C

Publication type:

Article

Impact of maternal hepatitis B virus coinfection on mother-to-child transmission of HIV.

Published in:

HIV Medicine, 2014, v. 15, n. 6, p. 347, doi. 10.1111/hiv.12120

By:

Mave, V;
Kadam, D;
Kinikar, A;
Gupte, N;
Bhattacharya, D;
Bharadwaj, R;
McIntire, K;
Kulkarni, V;
Balasubramanian, U;
Suryavanshi, N;
Thio, C;
Deshpande, P;
Sastry, J;
Bollinger, R;
Gupta, A;
Bhosale, R

Publication type:

Article